Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor-induced proliferation and maturation

被引:34
作者
Bhatia, R
Munthe, HA
Williams, AD
Zhang, F
Forman, SJ
Slovak, ML
机构
[1] City Hope Natl Med Ctr, Dept Hematol & Bone Marrow Transplantat, Duarte, CA 91010 USA
[2] City Hope Natl Med Ctr, Div Anat Pathol, Cytogenet Lab, Duarte, CA 91010 USA
关键词
chronic myelogenous leukemia; growth factors; stem cells; proliferation; differentiation;
D O I
10.1016/S0301-472X(00)00545-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. We investigated whether primary chronic myelogenous leukemia (CML) hematopoietic progenitors demonstrated altered proliferation and maturation in response to growth factor (GF) stimulation. Methods. The effect of GF stimulation on proliferation and expansion of committed and primitive progenitors (colony forming cells [CFC]) was evaluated. Results. Culture of CML and normal CD34(+) cells with different GF for 7 days resulted in similar expansion of committed progenitors (CFC). In contrast, GF culture conditions that expanded normal primitive progenitors (week-6 long-term culture-initiating cells (LTC-IC)] led to depletion of CML LTC-IC numbers. GF culture also resulted in increased depletion of week-10 extended LTC-IC, which represent an even more primitive progenitor population, from CML compared with normal CD34(+) cells. CR IL CD34(+) cells enter into cycle more quickly than normal CD34(+) cells and CML CFC expansion was accelerated compared to normal CFC, Evaluation of primitive progenitor proliferation using PKH-26 and single-cell LTC-IC analysis demonstrated that the majority of CML LTC-IC remaining after GF culture originated from divided CD34(+) cells, whereas GF-cultured normal LTC-IC were derived mainly from undivided cells. Depletion of CML primitive progenitor numbers in association with increased proliferation suggests increased sensitivity to GF-induced maturation. Conclusions. These studies indicate that CML primitive progenitors have enhanced sensitivity to GF-induced cell division and maturation. Altered GF responsiveness may contribute to abnormal expansion of malignant myeloid cells in CML. These findings may also be applied toward the development of novel approaches to select benign stem cells in CML. (C) 2000 International Society for Experimental Hematology. Published by Elsevier Science Inc.
引用
收藏
页码:1401 / 1412
页数:12
相关论文
共 40 条
[1]   Frequency of clonal B lymphocytes in chronic myelogenous leukemia evaluated by fluorescence in situ hybridization [J].
Al-Amin, A ;
Lennartz, K ;
Runde, V ;
Seeber, S ;
Opalka, B ;
Kloke, O .
CANCER GENETICS AND CYTOGENETICS, 1998, 104 (01) :45-47
[2]   APOPTOSIS IN CHRONIC MYELOID-LEUKEMIA - NORMAL RESPONSES BY PROGENITOR CELLS TO GROWTH-FACTOR DEPRIVATION, X-IRRADIATION AND GLUCOCORTICOIDS [J].
AMOS, TAS ;
LEWIS, JL ;
GRAND, FH ;
GOODING, RP ;
GOLDMAN, JM ;
GORDON, MY .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 91 (02) :387-393
[3]  
BEDI A, 1994, BLOOD, V83, P2038
[4]  
BEDI A, 1994, CANCER RES, V54, P5535
[5]   Murine stromal cells counteract the loss of long-term culture-initiating cell potential induced by cytokines in CD34+CD38low/neg human bone marrow cells [J].
Bennaceur-Griscelli, A ;
Tourino, C ;
Izac, B ;
Vainchenker, W ;
Coulombel, L .
BLOOD, 1999, 94 (02) :529-538
[6]  
Bhatia R, 1997, EXP HEMATOL, V25, P980
[7]   ABNORMAL FUNCTION OF THE BONE-MARROW MICROENVIRONMENT IN CHRONIC MYELOGENOUS LEUKEMIA - ROLE OF MALIGNANT STROMAL MACROPHAGES [J].
BHATIA, R ;
MCGLAVE, PB ;
DEWALD, GW ;
BLAZAR, BR ;
VERFAILLIE, CM .
BLOOD, 1995, 85 (12) :3636-3645
[8]   Interferon-alpha restores normal beta 1 integrin-mediated inhibition of hematopoietic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia [J].
Bhatia, R ;
McCarthy, JB ;
Verfaillie, CM .
BLOOD, 1996, 87 (09) :3883-3891
[9]   INTERFERON-ALPHA RESTORES NORMAL ADHESION OF CHRONIC MYELOGENOUS LEUKEMIA HEMATOPOIETIC PROGENITORS TO BONE-MARROW STROMA BY CORRECTING IMPAIRED BETA-1 INTEGRIN RECEPTOR FUNCTION [J].
BHATIA, R ;
WAYNER, EA ;
MCGLAVE, PB ;
VERFAILLIE, CM .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (01) :384-391
[10]   Stroma-contact prevents loss of hematopoietic stem cell quality during ex vivo expansion of CD34+ mobilized peripheral blood stem cells [J].
Breems, DA ;
Blokland, EAW ;
Siebel, KE ;
Mayen, AEM ;
Engels, LJA ;
Ploemacher, RE .
BLOOD, 1998, 91 (01) :111-117